
Biotherapeutics
Recent Developments using Chemical and Molecular Biology
- 336 pages
- English
- PDF
- Available on iOS & Android
About this book
This book illustrates the successful partnership of chemistry and biology to advance successful biotherapeutic modalities. Molecular design to create function is common to both chemical and molecular biology, and this text highlights recent developments from these disciplines that have delivered drugs, clinical candidates or significantly advanced biotherapeutic approaches.
Biotherapeutics are often considered to be beyond the reach of the medicinal chemist, but this book demonstrates that chemistry has an essential role in the future success of this area, by explaining and describing the chemical biology technologies that underpin specific therapeutic advances and demonstrating the unique value of molecular design and understanding.
Covering topics such as selective protein modification, immunopharmacotherapy, chemically programmed vaccinations, nanobodies and antibodies, this book provides essential reading for medicinal and pharmaceutical chemists working in both industry and academia.
Frequently asked questions
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Information
Table of contents
- Biotherapeutics
- Contents
- Chapter 1 Synthetic Immunology
- Chapter 2 Immunopharmacotherapy for Nicotine Addiction
- Chapter 3 Carbohydrate Vaccines
- Chapter 4 Generation and Maturation of Therapeutic Antibodies via In Vitro Somatic Hypermutation
- Chapter 5 Synthetic Protein Biologics
- Chapter 6 Recent Advances in Antibody–Drug Conjugates
- Chapter 7 MicroRNA Biotherapeutics: Key Challenges from a Drug Development Perspective
- Chapter 8 Novel Therapeutic Agents from Bacterial Toxins
- Chapter 9 Phage Selection of Mono- and Bicyclic Peptide Ligands
- Chapter 10 Chemical Approaches for Localization, Characterization and Mimicry of Peptide Epitopes
- Chapter 11 Cystine-Knot Micro-Proteins
- Subject Index